Navigation Links
New Research Reveals Need for Doctors to Know About Medical Tattoos
Date:4/21/2009

HOUSTON, April 21 /PRNewswire-USNewswire/ -- More people are turning to a new trend to let others know about their medical condition - tattooing. A case report will be presented Friday, May 15, at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress shedding light on this new phenomenon, while urging discussion from the medical community.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

One of the most obvious benefits of medical tattooing is for identification purposes in an emergency situation, especially for patients with diabetes, when a patient may be incapacitated - particularly in the case of hypoglycemic coma. However, it also poses some health concerns - ones that the study's primary author, Saleh Aldasouqi, MD, FACE, feels the medical community may need to weigh in on.

"Like it or not, tattooing for purposes of medical alerts is a phenomenon that is now occurring," Dr. Aldasouqi said. "It's imperative that the medical community take note and that, perhaps, appropriate regulation of the practice be proposed, especially for patients with diabetes."

Once that happens, Dr. Aldasouqi hopes that patients and their doctors can sit down, analyze the risks and benefits, and make an informed decision together.

Also at the 2009 AACE 18th Annual Meeting & Clinical Congress, diabetes experts will analyze the NICE-SUGAR study's impact on inpatient glycemic control. Other topics of interest include a look at the wide ranging impact of vitamin D in the human body, and clinical recommendations for the treatment of prediabetes - America's largest healthcare epidemic.

A short, one page bio and photo of Dr. Aldasouqi are available here.

Media Registration

Media Registration for the AACE 18th Annual Meeting & Clinical Congress is available free of charge to members of the working media online here. Additional press releases concerning the meeting are available online here.

About AACE

AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine diseases such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.

About the AACE Annual Meeting

The 18th Annual Meeting & Clinical Congress will be held in Houston, Texas, on May 13-17 at the George R. Brown Convention Center, Hilton Americas Houston. The AACE Annual Meeting & Clinical Congress is structured to provide relevant clinical information for the practicing endocrinologist. The programs will focus on information that allows endocrinologists to achieve the best solutions for the diagnosis and management of endocrine diseases. Pertinent scientific, clinical practice and patient management will be disseminated via general sessions, workshops, meet-the-experts and satellite symposia.


'/>"/>
SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument
2. Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors
3. New Research Shows Healthy Choice Lives Up To Its Name
4. Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia
5. Mayo Clinic researchers formulate treatment combination lethal to pancreatic cancer cells
6. USC researchers develop new drug to target tumor cells and blood vessels
7. Medarex Announces Clinical Data for MDX-1401 in Hodgkins Lymphoma at Annual Meeting of the American Association for Cancer Research
8. Mersanas Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
9. LSUHSC research shows fish oil protects against diseases like Parkinsons
10. Autism Science Foundation Launches Operations; New Advocacy Group Will Focus on Non-vaccine-related Autism Research
11. Research Takes Aim at Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: